Cargando…
MicroRNA-765 is upregulated in myelodysplastic syndromes and induces apoptosis via PLP2 inhibition in leukemia cells
BACKGROUND: Epigenetic studies, particularly research on microRNA (miRNA), have flourished. The abnormal expression of miRNA contributes to the development of hematologic malignancies. miR-765 has been reported to inhibit cell proliferation by downregulating proteolipid protein 2 (PLP2), which cause...
Autores principales: | Kang, Seong-Ho, Choi, Ji Seon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548289/ https://www.ncbi.nlm.nih.gov/pubmed/37495419 http://dx.doi.org/10.5045/br.2023.2023097 |
Ejemplares similares
-
MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2
por: Xiao, Wen, et al.
Publicado: (2020) -
MicroRNA-765 Enhances the Anti-Angiogenic Effect of CDDP via APE1 in Osteosarcoma
por: Liang, Wei, et al.
Publicado: (2017) -
MicroRNA-765 sensitizes osteosarcoma cells to cisplatin via downregulating APE1 expression
por: Liang, Wei, et al.
Publicado: (2019) -
The Role of Inhibition of Apoptosis in Acute Leukemias and Myelodysplastic Syndrome
por: McBride, Amanda, et al.
Publicado: (2019) -
Bromodomain-containing protein 4 silencing by microRNA-765 produces anti-ovarian cancer cell activity
por: Ji, Yong-Jun, et al.
Publicado: (2021)